UK government plans to widen the roll out of the Innova lateral flow test without supporting evidence risks serious harm, warn experts in The BMJ today.

LONDON – Final results of the community pilot in Liverpool, U.K., that used the controversial Innova Medical Group Inc. lateral flow device to test all comers for COVID-19, show new cases fell by 21% ...

Bond Digital Health Ltd. landed £1 million (US$1.3 million) from investors to expand development of its Transform data management system for lateral flow diagnostic tests. The technology connects to ...

Lateral flow test kits, which can provide results in just 30 minutes, are now available free through workplaces, at testing sites and via the post. The further expansion of testing will enable the ...

The proportion of people with current covid-19 infection missed by the Innova lateral flow test (LFT) is substantial enough to be of clinical importance, particularly when testing people without ...

"We are delighted to collaborate with Innova to support the manufacturing of its COVID-19 lateral flow test kits, right here in the UK where they'll be used," said Ian Morgan, General Manager ...

SYGNIS AG, under the Innova Biosciences (Innova) brand name, a specialist provider of bioconjugation products and services, today announced it has established a partnership with Abingdon Health Ltd ...

The lateral flow diagnostic is a cornerstone of the U.K. government’s Test and Trace program—with more than a billion units delivered to the country from factories in China, under contracts ...